MetaCap

Avalyn Pharma Statistics

NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.40-0.30 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Avalyn Pharma by the numbers

Avalyn Pharma has a market capitalization of $1.26 billion based on 44.52M shares outstanding. With trailing EPS of $-3.96, Avalyn Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% above its 50-day average and 4.9% below its 200-day average.

Average daily trading volume is 352.95K shares, or about $10.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AVLN valuation vs. peer median

AVLN compared with the median of 8 peer companies
MetricAVLNPeer medianDifference
Market cap$1.26B$1.24B+2%
Avg. volume352.95K1.98M-82%

Peer median across 8 companies: LBRX, INVA, MNKD, SLN, GENB, OCUL, NUVB, MLYS.

Valuation

Price and trading

Previous close
28.70
Open
28.06
Day range
27.85 – 29.38
52-week range
22.24 – 40.17
Beta
—
Volume
214.29K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
1.26B
Forward Pe
-11.01
Eps
-3.96
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.17
Week52 Low
22.24
Avg Volume
352.95K
Shares Outstanding
44.52M
Ma50
27.93
Ma200
29.86
Earnings Date
Nov 12, 2026
Pct From52w High
-29.30%
Pct From52w Low
27.70%

Related